Speaker illustration

Mr Elijah Genetzakis

University of Sydney, Sydney (Australia)

IL-1b as a potential biomarker and therapeutic target in coronary artery disease

Event: ESC Congress 2023

Topic: Biomarkers

Session: Immune mechanisms in myocardial diseases

Thumbnail